Post Content
Post Content
Post Content
Gilead, one of the few drugmakers in the HIV field, has ended a Phase 2/3 trial of two long-acting HIV pills that had been on hold...
WASHINGTON — Food and Drug Administration Commissioner Marty Makary recounted his agency’s achievements and acknowledged a “challenging start” to his tenure in a speech to staff...
In an interview, Chief Financial Officer Robin Kramer said the combined cash flow from Biogen and Apellis will not only help debt leverage ratios but also...
The weight loss startup Noom is banking its future on peptides, chemicals that are increasingly being touted for preventive health and longevity benefits despite little clinical...
Researchers headed by a team at Tel Aviv University have discovered that damaging variants in genes involved in a rapid immune response (innate immunity) are significantly...
The ALS Therapy Development Institute (ALS TDI), LifeArc, and Axol Bioscience launched the Patient induced pluripotent stem cell (iPSC)-based Research to Improve Sporadic ALS Modeling (PRISM)...
Ambient scribes were supposed to ease the burden on stressed-out doctors by automating clinical documentation from patient visits. A new study highlights the need to help...
Scan to Read